Ergebnis der Suchanfrage nach Website
Inhalte
- Kategorie:
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- 4Ein Dokumentmehr
Einladung zur Berichterstattung über die ordentliche Hauptversammlung der Deutsche Post AG am 5. Mai 2026 / Invitation to report on the annual general meeting of Deutsche Post AG on May 5, 2026
Einladung zur Berichterstattung über die ordentliche Hauptversammlung der Deutsche Post AG am 5. Mai 2026 Sehr geehrte Damen und Herren, hiermit laden wir Sie herzlich zur Berichterstattung über die ordentliche Hauptversammlung der Deutsche Post AG ...
2 Dokumentemehr- 3
Press Release - hubergroup Chemicals to present broad portfolio at the American Coatings Show 2026
Ein Dokumentmehr Press Release: Enzymatica and STADA sign partnership agreement for Germany and Austria
Press Release Enzymatica and STADA sign partnership agreement for Germany and Austria - New partnership agreement covers thelaunch and distribution of Enzymatica’s ColdZyme® oral-spray technology in Germany and Austria - Alliance combines Enzymatica’s clinically documented medical device with ...
Ein Dokumentmehr- 3
Press Release - hubergroup strengthens its position in the UV printing market through innovation and partnership
Ein Dokumentmehr Press Release - hubergroup Adjusts Prices in Europe Due to the Ongoing Middle East Conflict
Ein Dokumentmehr
- 2
Press Release: STADA’s Strong Growth Journey Continues in 2025
Ein Dokumentmehr Instone Group: Annual targets achieved; 2026 outlook assumes a significant increase in sales and earnings
Ein Dokumentmehr- 3
Press Release - hubergroup to showcase sustainable packaging solutions at ExpoPrint & ConverFlexo Latin America 2026
Ein Dokumentmehr - 2
Press Release - hubergroup Chemicals launches UHVPI-222200 for high-performance UV-curing coatings
Ein Dokumentmehr EUROEXPO Messe- und Kongress GmbH
LogiMAT 2026 | Future-focused initiative for innovation and skills in intralogistics
Munich, March 04, 2026 – EUROEXPO Messe- und Kongress-GmbH, the organizer of LogiMAT 2026, is featuring three forums in the accompanying program of events designed specifically to promote innovation in the ...
2 Dokumentemehr- 3
Press Release - hubergroup brings ink system TINKREDIBLE MGA to worldwide markets
Ein Dokumentmehr
- 4
EU-funded Research Project UNICO₂RN Converts Biogenic CO₂ into Proteins and Bioplastics
Ein Dokumentmehr - 5
Press Release - hubergroup Chemicals launches ELARA: tailored Additives
Ein Dokumentmehr Press Release: STADA invests more than €85m in Saudi Arabia manufacturing hub
Ein DokumentmehrPress Release: STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi
STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi - European Commission grants approval for Gotenfia®, a golimumab biosimilar to Simponi® that was developed by Bio-Thera and will be marketed by STADA ...
Ein Dokumentmehr- 2
Press release: Aurubis achieves quarterly result in line with market expectations and upgrades 2025/26 forecast
2 Dokumentemehr - 4
Press Release - hubergroup celebrates one year of success with DYNAMICA at PAMEX 2026
Ein Dokumentmehr
- 2
Press Release - hubergroup confirms full GIO compliance for packaging products
Ein Dokumentmehr Press release: STADA’s Head of Communications Frank Staud additionally leads Global Government Affairs
Ein Dokumentmehr- 2
Press Release - hubergroup Chemicals presents expanded portfolio at PAINT INDIA 2026
Ein Dokumentmehr Press Release: Golimumab biosimilar Gotenfia from STADA and Bio-Thera receives positive CHMP opinion
Golimumab biosimilar Gotenfia from STADA and Bio-Thera receives positive CHMP opinion - Positive opinion from European Medicines Agency supports approval for golimumab biosimilar Gotenfia® developed by Bio-Thera and to be marketed by STADA - ...
Ein Dokumentmehr- 2
Press release - High cash flow enables dividend uplift: Aurubis confirms sustainable growth strategy
2 Dokumentemehr Press Release: STADA welcomes Pedersen as General Counsel
Ein Dokumentmehr
Press Release: STADA obtains approvals to bring denosumab biosimilars in bone-health and oncology to patients in Europe
STADA obtains approvals to bring denosumab biosimilars in bone-health and oncology to patients in Europe - European Commission approves STADA’s Kefdensis® and Zvogra® denosumab biosimilars for all indications of reference medicines Prolia® and ...
3 DokumentemehrPress Release: STADA is in top 3% on pharma sustainability, Morningstar Sustainalytics assessment confirms
Ein DokumentmehrInstone Group: Very solid business performance in the first three quarters of 2025 with strong momentum in retail sales; annual targets for 2025 confirmed
Ein DokumentmehrPress Release: STADA Sponsors PingPongParkinson World Championship in Italy
Ein DokumentmehrInstone Group: Major investments in new land plots strengthen the basis for future growth
Ein DokumentmehrPM: Welthandel trotzt Zollturbulenzen - DHL Global Connectedness Tracker, Spezial-Update 2025 / PR: Global Trade Withstands Tariff Turbulence – DHL Global Connectedness Tracker, 2025 Special Update
3 Dokumentemehr